Detalhe da pesquisa
1.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Int J Cancer
; 148(6): 1478-1488, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33038277
2.
Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives.
Health Qual Life Outcomes
; 18(1): 10, 2020 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31931822
3.
Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification.
Int J Cancer
; 144(11): 2782-2794, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485423
4.
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
J Hepatol
; 68(5): 986-995, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29366909
5.
Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Am J Physiol Gastrointest Liver Physiol
; 314(3): G319-G333, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191940
6.
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy.
J Hepatol
; 67(1): 173-183, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28323121
7.
Validation of Clinical Scoring Systems ART and ABCR after Transarterial Chemoembolization of Hepatocellular Carcinoma.
J Vasc Interv Radiol
; 28(1): 94-102, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27562621
8.
Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors.
J Hepatol
; 65(6): 1188-1197, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27405060
9.
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.
J Hepatol
; 65(2): 280-8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26952006
10.
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients.
Clin Gastroenterol Hepatol
; 14(6): 875-886.e6, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26775025
11.
Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment.
BMC Cancer
; 16: 94, 2016 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26872727
12.
Overexpression of Bcl-3 inhibits the development of marginal zone B cells.
Eur J Immunol
; 44(2): 545-52, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24242374
13.
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma.
BMC Cancer
; 15: 210, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25884354
14.
Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients.
Liver Int
; 35(2): 591-600, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25290314
15.
Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
J Clin Gastroenterol
; 49(5): 438-47, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25014239
16.
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort.
BMC Gastroenterol
; 15: 97, 2015 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26239732
17.
The alpha and ßeta in phase II trials hepatocellular carcinoma - A tale of more than radiological response?
Liver Int
; 39(8): 1391-1393, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31368228
18.
Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
J Clin Gastroenterol
; 48(3): 279-89, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24045276
19.
Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP.
Am J Physiol Gastrointest Liver Physiol
; 303(4): G498-506, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22700824
20.
Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver.
Scand J Gastroenterol
; 47(6): 718-28, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22472070